Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-25 @ 4:28 PM
Study NCT ID:
NCT01984957
Status:
COMPLETED
Last Update Posted:
2015-03-23
First Post:
2013-06-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Differential Study of Muscle Transcriptome
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Study Overview
Official Title:
Differential Study of Muscle Transcriptome in Patients With Neuromuscular Disease and Control Subjects
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRANE
Brief Summary:
To isolate biomarkers of ALS in muscle
Detailed Description:
At present, there is no validated biological diagnostic marker for amyotrophic lateral sclerosis (ALS). The main objective of the study is to isolate a set of genes that are specifically dysregulated in muscle from ALS patients.
Gene profiling in muscle will be compared between ALS patients and patients with other motor neuron diseases (SMA and SBMA)
Gene profiling in muscle will be compared between ALS patients and patients with other motor neuron diseases (SMA and SBMA)
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: